BACK TO FUND'S DETAIL PAGE
All Holdings
All Holdings
185 Total Holdings:
As of 3/31/25
All Holdings:
1 -
15 of
185
| Security Name | Asset Type |
Shares or Principal Amount |
Market Value |
Percent of Net Assets 
|
|---|---|---|---|---|
| Broadcom, Inc. | Equity | 58,901,939 | $9,861,951,647.00 | 5.29% |
| Microsoft Corp. | Equity | 25,328,436 | $9,508,041,590.00 | 5.1% |
| Philip Morris International, Inc. | Equity | 43,256,225 | $6,866,060,594.00 | 3.68% |
| UnitedHealth Group, Inc. | Equity | 9,613,394 | $5,035,015,108.00 | 2.7% |
| Capital Group Central Cash Fund | Short Term | 49,354,949 | $4,935,494,888.00 | 2.65% |
| Marsh & McLennan Companies, Inc. | Equity | 19,528,345 | $4,765,502,030.00 | 2.55% |
| Apple, Inc. | Equity | 20,724,995 | $4,603,643,139.00 | 2.47% |
| Eli Lilly and Co. | Equity | 5,017,437 | $4,143,951,393.00 | 2.22% |
| JPMorgan Chase & Co. | Equity | 11,852,925 | $2,907,522,503.00 | 1.56% |
| Visa, Inc., Class A | Equity | 7,860,516 | $2,754,796,437.00 | 1.48% |
| Abbott Laboratories | Equity | 20,557,082 | $2,726,896,927.00 | 1.46% |
| BlackRock, Inc. | Equity | 2,855,252 | $2,702,438,913.00 | 1.45% |
| Amgen, Inc. | Equity | 8,190,823 | $2,551,850,906.00 | 1.37% |
| NVIDIA Corp. | Equity | 23,542,859 | $2,551,575,058.00 | 1.37% |
| AbbVie, Inc. | Equity | 11,601,403 | $2,430,725,957.00 | 1.3% |
All Holdings:
1 -
15 of
185